You searched for united kingdom - Page 7 of 55

Podcast 25 Aug 2023

Beyond Biotech podcast 60 – The cost of research

On this week’s podcast, we have a conversation with Dr Jack Scannell, CEO of Etheros Pharmaceuticals Corp. Scannell recently co-authored a paper on the expenses related to clinical research and…

August 25, 2023 - 1 minutemin - By Jim Cornall

News and Trends 28 Oct 2015

Dragen Bio-Processor: UK Partnership to Finally Sequence Domestic Wheat Genome

We still haven’t fully sequenced the domestic wheat genome! Now the US Dragen chip has the answer for speedy whole-genome analysis, which The Genome Analysis Centre (TGAC) in England will…

October 28, 2015 - 2 minutesmins - By Dani Bancroft

psychedelics psychiatric atai gh compass

News and Trends 24 Aug 2021

UK Venture Round Shines Spotlight on Europe’s Psychedelics Scene

The UK has cemented its position as a European hub for psychedelics research following a €68.5M ($80M) Series B round from the startup Beckley Psytech. The Oxford-based Beckley Psytech —…

August 24, 2021 - 4 minutesmins - By Jonathan Smith

News and Trends 30 Nov 2015

Heptares’ G-Protein StaR Platform has now Hooked Pfizer in a Billion Euro Deal

Heptares Therapeutics from the UK has landed Pfizer in a huge potential $1.9Bn deal for their G-protein receptor platform. Heptares Therapeutics was founded by Fiona Marshall (one of our Top…

November 30, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 28 Apr 2022

OMass Therapeutics Takes on ‘Undruggable’ Proteins with €90M Series B

The UK firm OMass Therapeutics has unveiled a €90M (£75.5M) Series B financing to bankroll the development of small molecules against so-called ‘undruggable’ targets, including one that sank Quench Bio…

April 28, 2022 - 3 minutesmins - By Jonathan Smith

News and Trends 1 Jun 2022

New treatment option available for Dravet syndrome

Global biopharma company UCB says the UK’s National Institute for Healthcare Excellence (NICE) has issued a positive Final Appraisal Determination (FAD) for its FINTEPLA (fenfluramine) oral solution. FINTEPLA is used…

June 1, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 22 Sep 2022

Promising MND drug slows disease progression

Scientists in the U.K. believe a new genetically-targeted therapy to treat motor neurone disease (MND) could be a turning point for patient care. Results from a phase 3 clinical trial…

September 22, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 31 Oct 2022

PhoreMost and Arvinas to collaborate on drug discovery against multiple therapeutic targets

U.K. biopharma company PhoreMost Ltd. has entered into a multi-target collaboration with Arvinas, a company active in targeted protein degradation (TPD). Under the terms of the agreement, PhoreMost will receive…

October 31, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 6 Jul 2016

June was a Tough Month for European Biotech… #Fail

Abivax, Celyad, Circassia and Genticel – these are all European Biotechs that took a hit after failing key clinical trials in June. How are they doing now? Four different public…

July 6, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 15 Nov 2022

Researchers awarded £2M to develop drugs to prevent epileptic seizures in children

Scientists at Aston University in the U.K. have started work on a project that will look for new drug treatments to prevent the onset of childhood epilepsy. The three-year Medical…

November 15, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 18 May 2023

Industry responds to UK science strategy launch

The UK Health Security Agency’s (UKHSA) has launched a 10-year science strategy, setting out how science can save more lives and contribute to the U.K.’s ambition of being a global…

May 18, 2023 - 7 minutesmins - By Jim Cornall

News and Trends 17 Nov 2017

British Biotech Gets Ready to Launch a New Antibiotic Drug to Fight Resistance

Update (17/11/2017): Motif Bio will raise up to $20M (€17M) in the form of a loan from US firm Hercules Capital. The funds will be used to fund the pre-commercialization…

November 17, 2017 - 3 minutesmins - By Alex Dale

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: united kingdom

Beyond Biotech podcast 60 – The cost of research

Dragen Bio-Processor: UK Partnership to Finally Sequence Domestic Wheat Genome

UK Venture Round Shines Spotlight on Europe’s Psychedelics Scene

Heptares’ G-Protein StaR Platform has now Hooked Pfizer in a Billion Euro Deal

OMass Therapeutics Takes on ‘Undruggable’ Proteins with €90M Series B

New treatment option available for Dravet syndrome

Promising MND drug slows disease progression

PhoreMost and Arvinas to collaborate on drug discovery against multiple therapeutic targets

June was a Tough Month for European Biotech… #Fail

Researchers awarded £2M to develop drugs to prevent epileptic seizures in children

Industry responds to UK science strategy launch

British Biotech Gets Ready to Launch a New Antibiotic Drug to Fight Resistance

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!